The dependence on time of the dose-effect relationship was studied for the removal o f 241 Am from the skeleton and liver o f the rat by C a-D TPA . Due to the linearity of the dose-effectcurves (in a log-log scale) as well as to the linear dependence o f the slope on the logarithm of time, simple equations were derived which describe the m obilization o f 241Am as influenced by DTPA-dosage and time of treatment.
A Multivariate Analysis of Ca-DTPA-Effectiveness in Removing 241 Am from the Rat

A . S e i d e l
In In general, the effectiveness of chelating agents in removing internally deposited radionuclides from the mammalian body depends markedly on the chelate dosage as well as on the time of treatm ent1. This holds also for the mobilization of 241Am by DTPA (diethylenetriaminepentaacetate)2"5. In this paper, which deals with the retention of 241Am in the rat, an attem pt is made to quantitize the influence of the factors mentioned above. Such an analysis of the effectiveness pattern should not only be the basis of understanding the action of multiple chelate doses but might also yield information about the metabolic behaviour of 241Am.
Methods
Female albino rats of the Heiligenberg-strain were intravenously injected with 241Am-citrate (0.3 «Ci in 0.25 ml; pH 7.5-8.5; prepared according to6) and received a single intraperitoneal injection of N a 3-[Ca-DTPA] at different times after 241 Am; the che late dosage ranged from 0.03-1.0 mmole • kg-1. For reasons discussed elsewhere5, the rats were sacrificed 7 days after administration of DTPA, excepted for those treated on the 64. day, which were killed 12 days after treatment. Details relating to the assay of a-activity of the organs by liquid scintillation coun ting are described elsewhere7. The 24,Am-content of the skeleton was calculated by multiplying by 20 the activity of one femur. In order to describe the chelate efficacy, the 241Am-content of liver and skeleton is presented as percentage of the corresponding control. Parts of the data were calculated from values pre sented earlier5. 
Results and Discussion
The dependence of chelate effectiveness on dosage as well as on the time of its administration is shown in Figs 1 and 2. The dose-effect curves were calcula ted by means of regression analysis and found to be linear in a log-log scale. Consequently, the dose-dependence can be described by the equation. log y = a + b log x where y. denotes the dosage [//mol • kg-1] and y the 241Am-content of the organ expressed as a percentage of the control. In the case of the liver, one experi mental point, i. e. 1 mmole • kg-1, injected after 1.5 min, was omitted from the calculation, since the effect of this dose is distinctly lower than the corres ponding extrapolated value of the linear regression line (Fig. 2) . By use of these equations it is possible to calculate dose-effect-functions for any given time as well as the time dependence of effectiveness for any given dose; the latter calculation is given in Fig. 4 and shows good fit between the experimental points and the calculated regression line. Nevertheless, the main ly formal nature of the equations should not be overlooked; one should be cautious with extrapo lation beyond the actually investigated limits of dosage and time.
A marked deviation from linearity, for example, is already evident in the case of the liver and the highest DTPA-dose, given after 1.5 min (Fig. 2) . However, the efficacy of lower doses (< 30 //moles • kg"1) is more interesting from the practical point of view. In order to elucidate this question, an addi tional experiment was performed: A DTPA-dose of [10 //moles • kg-1 was administered after 1.5 min or 24 hours. The 241Am-burden of the liver amounted to 24.7 and 78.0 % , respectively, of the control; that of the skeleton was 34.2 and 95.1 °/o respectively, of the control. These values compare quite well with those of the extrapolated regression lines in Figs 1 and 2. Thus, an extrapolation up to 10 /tmoles • kg-1 seems to be justified and feasible, at least for rela tively early times of treatment.
In our study, the decrease of chelate efficacy with increasing time interval was found to be paralleled by a corresponding decrease of the slope of the doseeffect-curves A common underlying mechanism may be assumed. Generally, the time-dependent loss of chelate efficacy suggests two possibilities: 1. The fraction of 241Am, which -due to its deposition site and/or its chemical reactivity -becomes unavailable to DTPA, increases with time. 2. 241 Am is retained from the very beginning by at least two com part ments which are characterized by different binding affinities to 241Am and, thus, by a different residence time of 241 Am as well as different response to DTPA ; with increasing time, the loosely bound fraction be comes depleted due to spontaneous excretion, and the effect of DTPA becomes limited because of the pre valence of the tightly bound fraction. It can be easily verified numerically that the existence of a multicompartment system as outlined above will lead to a decrease of the slope of the dose-effect curves with increasing time.
Taking into account that the skeletal burden of 241Am remains virtually constant over long periods of time, we are obviously dealing with situation 1. in this case, i. e., in terms of the compartment ana lysis, with a so-called catenary system. The response of the liver, from which spontaneous elimination is a rather fast process in the rat4> 8>9, is, shortly speak ing, compatible with both assumptions. However, the repeatedly mentioned fact that the influence of the highest dose, administered after 1.5 min, is distinctly lower than should be expected on the basis of the linear dose-effect relationship for doses between 10 and 300 /<moles • kg-1 (Fig. 2) may be taken as evi-dence in favour of the situation 2., i. e., of a so-called mammillary compartment system. The assumption of more than tw o 241Am-compartments in bone and liver is corroborated by autoradiographic and biochemical findings10' 13.
The behaviour of the intercept a (Fig. 3) suggests that -in addition to the heterogeneity of the bind ing sites mentioned above -two basically different phases of DTPA-efficacy are involved. Indeed, it has been shown14 that after intravenous injection of 241Am-citrate there is a significant amount of activity in the blood plasma only up to about 90 min. Conse quently, during this time interval interaction of DTPA with 241Am takes place mainly in the plasma, i. e., we are dealing with a prevention of 241Am-deposition, whereas after about 90 min a genuine mobilization from the organs dominates.
It has been pointed out by T r e g u b e n k o et al. 15 that the use of chelating agents might yield some in formation about the metabolic behaviour of radio nuclides in the body, not accessible to biochemical and/or histological methods. Although the functions derived from the present study reflect changes of the binding of 241 Am by different endogenous ligands, it
is not yet possible -due to the complex nature of these functions and, in particular, the lack of addi tional data -to correlate our findings with concrete physiological and biochemical processes.
